Previous Article | Next Article 
Infection and Immunity, November 1999, p. 5946-5950, Vol. 67, No. 11
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Recognition of Schistosome Glycolipids by
Immunoglobulin E: Possible Role in Immunity
Desiree
van der
Kleij,1,2
Aloysius G. M.
Tielens,2 and
Maria
Yazdanbakhsh1,*
Department of Parasitology, Leiden University
Medical Center, Leiden,1 and Department
of Biochemistry and Cell Biology, Faculty of Veterinary Medicine,
Utrecht University, Utrecht,2 The Netherlands
Received 22 March 1999/Returned for modification 17 May
1999/Accepted 16 August 1999
 |
ABSTRACT |
To investigate the role of antibody responses to (glyco)lipids in
immunity to schistosome infection, lipids extracted from Schistosoma mansoni eggs and adult worms were fractionated,
and the antibody isotype profile reactive to the fractionated lipids in
a well-characterized S. haematobium-infected population was investigated. In tests of 10 plasma samples it was found that immunoglobulin G (IgG) reactivity was highest to the fraction containing ceramidepolyhexosides, whereas IgE reactivity was most prominent to both cerebroside- and ceramidepolyhexoside-containing fractions. The fraction containing ceramidepolyhexosides was then tested for reactivity with IgG subclasses and IgE in plasma samples from 66 S. haematobium-infected patients. Considering IgG4
and IgE, isotypes of particular interest in helminth infections, we found that both isotypes recognized egg (glyco)proteins in more than
90% of the infected subjects. However, in the case of glycolipids, IgE
reactivity was much more prominent than IgG4 reactivity (found in 80 and 41% of the subjects, respectively). Furthermore, worm glycolipid-specific IgE prior to treatment of the subjects with praziquantel was negatively correlated with egg counts at 2 years posttreatment, indicating that IgE directed towards glycolipids could
play an important role in resistance to reinfection.
 |
INTRODUCTION |
In recent years, the regulation of
immune responses in schistosome infections has been a topic of great
interest. In particular, the role of antibodies in resistance or
susceptibility to reinfection has been studied intensively. Helminth
infections are characterized by elevated levels of immunoglobulin E
(IgE) and IgG4 antibodies, isotypes which are normally expressed at
very low levels. In schistosomiasis, the balance between these two
isotypes is thought to play a role in resistance or susceptibility to
infection. Immunoepidemiological studies have established a clear
age-related resistance to infection, with children being more
susceptible than adults (7, 11, 12). IgE levels are low in
children and high in adults, whereas for IgG4 the reverse has been
found (7, 12). Therefore, IgE has been implicated in
protection against reinfection, whereas IgG4 has been associated with
susceptibility to reinfection (4, 7, 12). Furthermore, since
IgG4 and IgE can display parallel specificity spectra (13,
17), it has been postulated that IgG4 acts as a blocking antibody
for IgE-mediated protective effector functions (12).
Many antigenic determinants of various schistosome life cycle stages
are carbohydrate in nature (for a review, see reference 2). So far, the detailed characterization of
antigens that are recognized by IgE and IgG4 has involved studying
protein or glycoprotein components of schistosomes either directly or
by cloning (14, 21). However, carbohydrate moieties not only occur on proteins but also can be lipid bound. In fact, there is a
remarkable overlap in the occurrence of immunogenic carbohydrate epitopes on proteins and lipids (22). Recent studies by
Dennis et al. (5) have shown that glycolipids extracted from
Schistosoma mansoni adult worms can be recognized by IgG
antibodies in sera from S. mansoni- and Schistosoma
haematobium-infected individuals, indicating that glycolipids may
play an active role in shaping immune responses to schistosomes.
To characterize antibody responses to (glyco)lipids in immune responses
mounted during a schistosome infection, we have examined the antibody
isotype profile reactive to these moieties in a well-characterized S. haematobium-infected population, focusing on IgG4 and
IgE. To further clarify the potential role of antibodies directed to glycolipids in protective immunity, we used plasma samples from individuals who were classified as resistant or susceptible to reinfection 2 years after treatment with praziquantel.
 |
MATERIALS AND METHODS |
Study population.
The study population was from an area in
Lambaréné, Gabon, where S. haematobium is
endemic and has previously been described (10, 11). Plasma
samples used were from 66 infected individuals, 38 children (5 to 14 years) and 28 adults (15 to 48 years), who have been described in
detail before (10, 11). The adults selected had egg output
(geometric mean, 111 eggs/10 ml of urine; range, 4 to 2,073 eggs/10 ml
of urine) at levels equivalent to those for the children (geometric
mean, 107 eggs/10 ml of urine; range, 11 to 3,230 eggs/10 ml of urine).
Thus, egg output was not a variable that could affect pretreatment
antibody reactivity. Samples that were taken immediately prior to
treatment with praziquantel and 2 years thereafter were used. Two years
after treatment, 33 subjects were reinfected and 24 subjects remained
uninfected; the other subjects had left the study area or refused to
participate in the study, as detailed before (11). For the
study described here, posttreatment plasma samples from 20 reinfected
and 15 uninfected subjects were available. Viable eggs in urine were
counted, the level of circulating anodic antigen in plasma was
determined, and the combined reagent strip index was calculated as a
marker for acute pathology in the lower urinary tract as described
previously (10). The results of these tests are shown in
Table 1.
Antigen preparation.
Although plasma samples from S. haematobium-infected individuals were used in this study, the
limited availability of S. haematobium parasite material
prompted us to use antigens from S. mansoni, since previous
studies have indicated that there is extensive cross-reactivity between
S. mansoni and S. haematobium glycoprotein and
glycolipid antigens (5, 15, 19).
S. mansoni adult worms were collected by perfusion of golden
hamsters 45 to 48 days after infection. S. mansoni eggs were isolated from livers of infected hamsters after treatment of the liver
homogenate with trypsin (6). Adult worm antigens (AWA) and
soluble egg antigens (SEA) were prepared as described previously (3).
Lipids of
S. mansoni adult worms (12 g [wet weight]) and
eggs (1.6 g [wet weight]) were extracted by the method described
by
Bligh and Dyer (
1). The organic phase was dried by rotary
evaporation, dissolved in 10 ml of chloroform, and applied to
a 20-ml
column of the anion exchanger TEAE-cellulose (Serva, Heidelberg,
Germany) that was converted to the hydroxyl form. Lipids were
eluted as
described by Rouser et al. (
18). According to this
protocol,
the fractions contain the following lipids: fraction
1, cholesterol,
glycerides, and other neutral lipids; fraction
2, cerebrosides,
glycerol diglycerides, phosphatidylcholine, and
sphingomyelin; fraction
3, ceramidepolyhexosides; fraction 4,
inorganic substances; fraction 5, phosphatidylethanolamine and
free fatty acids; fraction 6, phosphatidylserine; fraction 7,
none (washing step); and fraction 8, phosphatidic acid, cardiolipin,
phosphatidylglycerol,
phosphatidylinositol, and other acidic lipids.
The presence of
glycolipids in fractions 2 and 3 was confirmed
by orcinol staining of
the lipid fractions on HPTLC plates (
20).
Antibody analysis.
PolySorp microtiter plates (Nunc,
Roskilde, Denmark) were coated overnight at room temperature with SEA
or AWA (5 µg/ml in 0.035 M phosphate-buffered saline-0.15 M NaCl
[pH 7.6] [PBS]) or with methanol-dissolved lipids (0.1% of the
worm fractions and 0.25% of the egg fractions per well; for fraction 3 this is equivalent to 33 ng per well for worm glycolipids and 17 ng per well for egg glycolipids). Lipid-coated plates were air dried overnight. The following incubations were at 37°C with shaking in a
total volume of 100 µl per well, unless stated otherwise. Between
each incubation, plates were washed five times with PBS-0.01% Tween
20. Plates were blocked by a 1-h incubation with 200 µl of blocking
solution (0.07% [wt/vol] bovine nonfat dry milk in PBS). To control
for nonspecific binding, plates coated with blocking solution (1 h)
were tested. Plasma samples as well as detection antibodies were
diluted in blocking solution. Plates were incubated with plasma
dilutions (60 min at a 1/100 dilution for total IgG; 90 min at 1/20 for
IgG2, IgG4, and IgE; and overnight at 1/100 at 4°C for IgG1) and then
with horseradish peroxidase-conjugated anti-human IgG1 (120 min,
1/3,000; CLB, Amsterdam, The Netherlands) or with biotin-conjugated (i)
goat anti-human total IgG (60 min, 1/10,000; Vector, Burlingame,
Calif.), (ii) goat anti-human IgE (90 min, 1/1,000; Vector), (iii)
monoclonal anti-human IgG4 (90 min, 1/3,000; CLB), or (iv) monoclonal
anti-human IgG2 (90 min, 1/1,000; Sigma, St. Louis, Mo.). The plates
(except those for IgG1) were further incubated for 1 h with
streptavidin-horseradish peroxidase (1/10,000; Central Laboratory for
Blood Transfusion, Amsterdam, The Netherlands). Assays were developed
at room temperature with 3,3',5,5'-tetramethylbenzidine as the
substrate. Reactions were stopped by adding 2 M
H2SO4, and absorbance was read at 450 nm in an
automated plate reader. For analysis, the optical density (OD) of each
plasma sample on the blocking solution-coated plates was subtracted
from the OD of the antigen-coated plates. Plasma samples from healthy
Dutch donors were used as negative controls to calculate the cutoff OD
values (these values were not significantly different from values
obtained when plasma samples with high levels of total IgE from
Indonesian donors with intestinal helminth infections but without
schistosomiasis were used). IgG3 was excluded from this study due to
technical problems with the assay, as in our hands all anti-human IgG3
conjugates tested showed cross-reactivity with other isotypes.
Statistical analysis.
The relationship between antibody
levels and egg output was examined by a Spearman rank correlation test.
The Wilcoxon matched-pairs signed-rank test was used for comparison of
pre- and posttreatment measurements; a Mann-Whitney U test was used to
compare data between uninfected and reinfected groups.
 |
RESULTS |
Recognition of S. mansoni lipid fractions by infection
sera.
Lipids extracted from S. mansoni eggs were
fractionated by TEAE-cellulose column chromatography, and antigenicity
was analyzed by enzyme-linked immunosorbent assay (ELISA). Binding of
IgG and IgE to the lipid fractions was monitored with plasma samples
from 10 S. haematobium-infected individuals (Fig.
1). IgG reacted most strongly with
fraction 3, containing ceramidepolyhexosides, whereas IgE reactivity
was high against both fraction 3, containing ceramidepolyhexosides, and
fraction 2, containing cerebrosides. In control plasma samples from 10 healthy Dutch donors antibody binding was low and no differences in
reactivity to the various lipid fractions were observed. Results obtained with lipids extracted from S. mansoni adult worms
were comparable (data not shown).

View larger version (14K):
[in this window]
[in a new window]
|
FIG. 1.
Binding of IgG and IgE to lipid fractions extracted from
S. mansoni eggs in 10 plasma samples from S. haematobium-infected individuals. Antibody reactivities are
plotted as ODs at 450 nm. The mean ODs plus two times the standard
deviations for the healthy Dutch donors were 0.114 for IgG and 0.074 for IgE.
|
|
Subclass reactivity to glycolipids.
The reactivities of IgG1,
IgG2, IgG4, and IgE to the fraction containing ceramidepolyhexosides
(glycolipids) of S. mansoni eggs and adult worms were
characterized by ELISA with plasma samples from 66 S. haematobium-infected subjects (Table 1). Reactivity to glycolipids
was compared to binding of antibodies to (glyco)protein extracts of
adult worms (AWA) and eggs (SEA). Ten plasma samples from healthy Dutch
donors were used as negative controls. For each isotype the percentage
of positive plasma samples was calculated, as shown in Table
2. Almost all plasma samples from
infected subjects showed binding of IgG1 to proteins that were present in SEA, whereas only 56% of the samples showed IgG1 binding to the
egg-derived glycolipids. In the case of IgG2, 58% of the samples contained IgG2 directed to SEA, and 41% contained IgG2 specific for
egg glycolipids. The recognition pattern of IgG4 was comparable to that
of IgG1; reactivity of IgG4 was particularly high to SEA and was
substantial to AWA. In contrast, only 41 and 26% of the plasma samples
contained IgG4 specific for glycolipids of eggs and worms,
respectively. These findings indicate a limited reactivity of IgG1 and
IgG4 to glycolipids. Remarkably, IgE reactivities to the protein
extracts and to the glycolipids were comparable, being particularly
high for egg antigens (>95%). In the case of adult worms, IgE
reactivity to components of the protein extract and the glycolipid
fraction was found in 59 and 55% of the samples, respectively. For all
isotypes, subjects positive for antibodies to glycolipids were also
positive for antibodies to the protein extracts.
View this table:
[in this window]
[in a new window]
|
TABLE 2.
Percentages of S. haematobium-infected
subjects positive for binding of IgG1 IgG2, IgG4, and IgE to SEA,
glycolipids of eggs, AWA, and glycolipids of adult worms
|
|
Differential recognition of glycolipids by IgG4 and IgE.
Given
that IgE and IgG4 are the isotypes of most interest in helminth
infections, we compared the reactivities of IgE and IgG4 to glycolipids
and protein extracts (Fig. 2). For SEA
and AWA, most plasma samples contained both IgE and IgG4 specific for
components in these extracts. However, a substantial proportion of the
samples was found to be positive for IgE directed to glycolipids but
negative for IgG4 directed to these components, indicating preferential
IgE binding to glycolipids relative to IgG4 binding.

View larger version (22K):
[in this window]
[in a new window]
|
FIG. 2.
Pretreatment IgE and IgG4 reactivities to AWA (A),
glycolipids of adult worms (B), SEA (C), and glycolipids of eggs (D).
Antibody reactivities are plotted as ODs at 450 nm. Each plot is
divided by a horizontal line representing the mean plus two times the
standard deviation for the healthy Dutch donors for IgG4 and by a
vertical line representing the mean plus two times the standard
deviation for the healthy Dutch donors for IgE.
|
|
Relationship between antibody isotypes and susceptibility to
reinfection.
The study population described here was treated with
praziquantel, and plasma samples were taken immediately prior to
treatment and 2 years thereafter (10, 11). Previously, a
correlation between pretreatment IgE specific for AWA and posttreatment
egg counts was found, indicating that IgE directed to AWA may play a
role in resistance to reinfection (7, 11, 12). To determine the predictive value of antibodies directed to glycolipid antigens in
resistance to reinfection, the relationship between pretreatment antibody levels and posttreatment egg counts was determined. IgE reactivity to glycolipids of worms was significantly higher in individuals who were resistant to reinfection after treatment than in
subjects who were reinfected at 2 years posttreatment (P = 0.025). Furthermore, pretreatment IgE specific for glycolipids derived from worms was negatively correlated with posttreatment egg
counts (r =
0.371; P = 0.029) (Table
3). For AWA the same trend was observed;
however, in the present study, where fewer plasma samples were
available, the association did not reach statistical significance
(r =
0.274; P = 0.111). No significant
correlation with posttreatment egg counts was found for IgE to egg
glycolipids and SEA or for other antibody isotypes directed to any of
the antigen preparations.
In a previous study by our group, a correlation between pretreatment
SEA-specific IgG4 responses and pretreatment egg counts
was found
(
10). To determine if this association also exists
for
antibodies directed to glycolipids, correlations between pretreatment
egg counts and pretreatment specific IgG4 responses were calculated.
Pretreatment egg counts were found to correlate positively with
pretreatment IgG4 specific for glycolipids of eggs (
r = 0.325;
P = 0.008) and SEA (
r = 0.374;
P = 0.002). In addition, we found
that individuals infected at 2 years
posttreatment had significantly
higher levels of IgG4 to egg
glycolipids and SEA than uninfected
subjects (
P = 0.035
for egg glycolipids;
P = 0.025 for SEA). For
AWA, there
was no significant difference in IgG4 to AWA and adult
worm glycolipids
between these groups. Moreover for IgG1, IgG2,
and IgE, no differences
in antibody levels to proteins or glycolipids
derived from eggs or
adult worms were found between uninfected
and reinfected
subjects.
 |
DISCUSSION |
Several immunoepidemiological studies have examined antibody
isotype responses to schistosomal protein extracts. In this study we
have extended this analysis to antibody isotypes reactive to schistosome lipids and glycolipids, using plasma samples from a
well-characterized S. haematobium-infected population. It
was clearly shown that the ceramidepolyhexoside-containing fraction of
lipids extracted from schistosomes is a prime target of IgG antibody
responses. The peak IgE reactivity was equally distributed over the
cerebroside- and ceramidepolyhexoside-containing fractions. To evaluate
the role of glycolipids in the immune responses mounted to
schistosomes, we measured specific IgG subclasses (IgG1, IgG2, and
IgG4) and IgE antibodies directed to schistosome glycolipids and
(glyco)protein extracts in plasma samples from S. haematobium-infected subjects before and 2 years after treatment.
Reactivity of IgG1 was prominent to SEA and lower to glycolipids of
eggs, whereas IgG2 reactivities to SEA and glycolipids were equivalent.
This implies that for binding of IgG1, peptide epitopes are important, while IgG2 recognizes mainly epitopes that are carbohydrate in nature.
When considering IgG4 and IgE, it was striking that IgE reactivity to
glycolipids extracted from schistosome eggs or adult worms was more
prominent than IgG4 responses. This pattern was distinct from responses
to SEA or to AWA, where IgG4 responses were comparable or more
predominant. Thus, in our study subjects, glycolipids are
preferentially recognized by IgE antibodies. In the study on antibody
responses to glycolipids performed by Dennis et al., no IgE reactivity
to a comparable glycolipid fraction extracted from S. mansoni and S. haematobium adult worms was found (5). To some extent this may be attributable to higher serum dilutions used in the ELISA in that study (1/40) compared to ours (1/20). In the same study, in 1 of 10 plasma samples IgG4 was found to
be a prominent part of the IgG reactivity to schistosome glycolipids at
a plasma dilution of 1/1,500, whereas in the study presented here, we
did not find high IgG4 reactivity to glycolipids in any of the 66 samples with a 1/20 plasma dilution. This finding cannot be explained
by the sensitivity of the ELISA used here being too low to measure
glycolipid-specific IgG4, because high levels of IgG4 directed to SEA
and AWA could be detected. Thus, it remains possible that either
methodological or patient-related differences account for the
difference in IgG4 reactivity between the study presented here and the
study performed by Dennis et al. (5). It should be realized
however, that the neutral glycolipid fraction used by Dennis et al. is
equivalent to the glycolipid fractions used by us. In our study the
neutral glycolipids were not in a single fraction but were further
separated into fractions 2 and 3.
The preferential reactivity of IgE with glycolipids is of particular
interest in two ways. Regulation of IgG4 and IgE is thought to be
coordinated via Th2 cytokines interleukin-4 and interleukin-13 (9). So far, switch studies have shown that the presence of these cytokines will drive a switch to both IgG4, produced in large
amounts, and IgE, synthesized at more modest levels (16). The existence of conditions where IgE responses are produced
preferentially has to imply that glycolipids stimulate T cells that are
particularly adapted for providing switch signals for IgE, possibly in
a CD1-restricted manner. Interestingly, it was reported recently by
Fujieda et al. that a CD1-restricted T-cell interaction with antigen
can influence the antibody isotype production (8).
Alternatively, glycolipids could suppress the development of
IgG4-producing B cells. In addition, since IgE antibodies are
considered to play an important role in protective immunity in
schistosomiasis, whereas IgG4 is thought to block protective effector
functions of IgE, a closer characterization of structures that
preferentially bind IgE becomes important when considering preventive
measures. Indeed, the importance of IgE antibodies directed to
glycolipids is further strengthened by the finding that pretreatment
levels of IgE specific for adult worm glycolipids were negatively
correlated with posttreatment egg counts, indicating that IgE directed
to these glycolipids may play a role in resistance to reinfection.
Glycoconjugates, both glycoproteins and glycolipids, are present in all
life cycle stages of schistosomes. It was shown by Weiss et al. that a
carbohydrate epitope recognized by a monoclonal antibody that was
raised against the cercarial glycocalyx was present on glycoproteins
and glycolipids of various schistosome life cycle stages
(22). It is uncertain whether the production of the
anticarbohydrate antibodies measured in the present study was
stimulated by glycolipids, glycoproteins, or both. So far, our results
indicate that proteins alone do not constitute the major binding
targets of IgE but that this isotype is substantially directed towards
carbohydrate moieties that can be linked to the ceramide portion of
glycolipids or proteins present in SEA or AWA. Moreover, this study
shows that IgE antibodies reactive with glycolipids may play a role in
immunity to schistosomes. It should be noted that the glycolipid
extract used here presumably consists of a mixture of glycolipids which
can vary both in the carbohydrate part and in the lipid part.
Purification and characterization of the structures that preferentially
induce IgE antibodies may provide insight into the mechanisms that are
important in regulation of IgE and possible resistance to infection.
 |
ACKNOWLEDGMENTS |
We thank P. Kremsner and J. Grogan for their help with collection
of plasma samples and A. Deelder, D. Kornelis, and M. Schmitz for
providing S. mansoni material.
This work was supported by the Netherlands Foundation for Chemical
Research (SON) and the Earth and Life Science Foundation (ALW), with
financial support from The Netherlands Organization for Scientific
Research (NWO).
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Dept. of
Parasitology, Leiden University Medical Center, P.O. Box 9605, 2300 RC
Leiden, The Netherlands. Phone: 31 71 5276861. Fax: 31 71 5276850. E-mail: maria{at}rullf2.MedFac.LeidenUniv.nl.
Editor:
S. H. E. Kaufmann
 |
REFERENCES |
| 1.
|
Bligh, E. G., and W. J. Dyer.
1959.
A rapid method of total lipid extraction and purification.
Can. J. Biochem. Physiol.
37:911-917.
|
| 2.
|
Cummings, R. D., and A. K. Nyame.
1996.
Glycobiology of schistosomiasis.
FASEB J.
10:838-848[Abstract].
|
| 3.
|
Deelder, A. M.,
D. Kornelis,
M. Makbin,
H. N. Noordpool,
R. M. Codfried,
J. P. Rotmans, and B. F. J. Oostburg.
1980.
Applicability of different antigen preparations in the enzyme-linked immunosorbent assay for schistosomiasis mansoni.
Am. J. Trop. Med. Hyg.
29:401-410.
|
| 4.
|
Demeure, C. E.,
P. Rihet,
L. Abel,
M. Ouattara,
A. Bourgois, and A. J. Dessein.
1993.
Resistance to Schistosoma mansoni in humans: influence of the IgE/IgG4 balance and IgG2 in immunity to reinfection after chemotherapy.
J. Infect. Dis.
168:1000-1008[Medline].
|
| 5.
|
Dennis, R. D.,
S. Baumeister,
G. Lauer,
R. Richter, and E. Geyer.
1996.
Neutral glycolipids of Schistosoma mansoni as feasible antigens in the detection of schistosomiasis.
Parasitology
112:295-307.
|
| 6.
|
Dresden, M. H., and D. C. Payne.
1981.
A sieving method for the collection of schistosome eggs from mouse intestines.
J. Parasitol.
67:450-452[Medline].
|
| 7.
|
Dunne, D. W.,
A. E. Butterworth,
A. J. C. Fulford,
H. C. Kariuki,
J. G. Langley,
J. H. Ouma,
A. Capron,
R. J. Pierce, and R. F. Sturrock.
1992.
Immunity after treatment of human schistosomiasis: association between IgE antibodies to adult worm antigens and resistance to reinfection.
Eur. J. Immunol.
22:1483-1494[Medline].
|
| 8.
|
Fujieda, S.,
P. A. Sieling,
R. L. Modlin, and A. Saxon.
1998.
CD1-restricted T-cells influence IgG subclass and IgE production.
J. Allergy Clin. Immunol.
101:545-551[Medline].
|
| 9.
|
Gascan, H.,
J. F. Gauchat,
M. G. Roncarolo,
H. Yssel,
H. Spits, and J. E. de Vries.
1991.
Human B cell clones can be induced to proliferate and to switch to IgE and IgG4 synthesis by interleukin 4 and a signal provided by activated CD4+ T cell clones.
J. Exp. Med.
173:747-750[Abstract/Free Full Text].
|
| 10.
|
Grogan, J. L.,
P. G. Kremsner,
G. J. van Dam,
W. Metzger,
B. Mordmuller,
A. M. Deelder, and M. Yazdanbakhsh.
1996.
Antischistosome IgG4 and IgE responses are affected differentially by chemotherapy in children versus adults.
J. Infect. Dis.
173:1242-1247[Medline].
|
| 11.
|
Grogan, J. L.,
P. G. Kremsner,
G. J. van Dam,
A. M. Deelder, and M. Yazdanbakhsh.
1997.
Anti-schistosome IgG4 and IgE at 2 years after chemotherapy: infected versus uninfected individuals.
J. Infect. Dis.
176:1344-1350[Medline].
|
| 12.
|
Hagan, P.,
U. J. Blumenthal,
D. Dunn,
A. J. G. Simpson, and H. A. Wilkins.
1991.
Human IgE, IgG4 and resistance to reinfection with Schistosoma haematobium.
Nature
349:243-245[Medline].
|
| 13.
|
Hussain, R., and E. A. Ottesen.
1986.
IgE responses in human filariasis. IV. Parallel antigen recognition by IgE and IgG4 subclass antibodies.
J. Immunol.
136:1859-1863[Abstract].
|
| 14.
|
Li, Z.,
C. L. King,
J. O. Ogundipe,
L. S. Licate, and R. E. Blanton.
1995.
Preferential recognition by human IgE and IgG4 of a species-specific Schistosoma haematobium serine protease inhibitor.
J. Infect. Dis.
171:416-422[Medline].
|
| 15.
|
Norden, A. P., and M. Strand.
1984.
Schistosoma mansoni, S. haematobium and S. japonicum: identification of genus-, species-, and gender-specific antigenic worm glycoproteins.
Exp. Parasitol.
57:110-123[Medline].
|
| 16.
|
Punnonen, J.,
G. Aversa,
B. G. Cooks,
A. N. J. McKenzie,
S. Menon,
G. Zurawski,
R. de Waal Malefyt, and J. E. de Vries.
1993.
Interleukin 13 induces interleukin 4-independent IgG4 and IgE synthesis and CD23 expression by human B cells.
J. Immunol.
90:3730-3734.
|
| 17.
|
Rihet, P.,
C. E. Demeure,
A. J. Dessein, and A. Bourgois.
1992.
Strong serum inhibition of specific IgE correlated to competing IgG4, revealed by a new methodology in subjects from a S. mansoni endemic area.
Eur. J. Immunol.
22:2063-2070[Medline].
|
| 18.
|
Rouser, G.,
G. Kritchevsky,
A. Yamamoto,
G. Simon,
C. Galli, and A. J. Bauman.
1969.
Diethylaminoethyl and triethylaminoethyl cellulose column chromatographic procedures for phospholipids, glycolipids, and pigments.
Methods Enzymol.
14:272-317.
|
| 19.
|
Simpson, A. J. G.,
F. Hackett,
C. Kelly,
M. Knight,
G. Payares,
P. Omer-Ali,
J. Lillywhite,
S. L. Fleck, and S. R. Smithers.
1986.
The recognition of Schistosoma mansoni surface antigens by antibodies from patients infected with S. mansoni and S. haematobium.
Trans. R. Soc. Trop. Med. Hyg.
80:261-270[Medline].
|
| 20.
|
Svennerholm, L.
1956.
Quantitative estimation of cerebrosides in nervous tissue.
J. Neurochem.
1:42-53[Medline].
|
| 21.
|
Webster, M.,
A. J. C. Fulford,
G. Braun,
J. H. Ouma,
H. C. Kariuki,
J. C. Havercroft,
K. Gachuhi,
R. F. Sturrock,
A. E. Butterworth, and D. W. Dunne.
1996.
Human immunoglobulin E responses to a recombinant 22.6-kilodalton antigen from Schistosoma mansoni adult worms are associated with low intensities of reinfection after treatment.
Infect. Immun.
64:4042-4046[Abstract].
|
| 22.
|
Weiss, J. B.,
J. L. Magnani, and M. Strand.
1986.
Identification of Schistosoma mansoni glycolipids that share immunogenic carbohydrate epitopes with glycoproteins.
J. Immunol.
136:4275-4282[Abstract].
|
Infection and Immunity, November 1999, p. 5946-5950, Vol. 67, No. 11
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Naus, C. W. A., van Remoortere, A., Ouma, J. H., Kimani, G., Dunne, D. W., Kamerling, J. P., Deelder, A. M., Hokke, C. H.
(2003). Specific Antibody Responses to Three Schistosome-Related Carbohydrate Structures in Recently Exposed Immigrants and Established Residents in an Area of Schistosoma mansoni Endemicity. Infect. Immun.
71: 5676-5681
[Abstract]
[Full Text]
-
van der Kleij, D., Latz, E., Brouwers, J. F. H. M., Kruize, Y. C. M., Schmitz, M., Kurt-Jones, E. A., Espevik, T., de Jong, E. C., Kapsenberg, M. L., Golenbock, D. T., Tielens, A. G. M., Yazdanbakhsh, M.
(2002). A Novel Host-Parasite Lipid Cross-talk. SCHISTOSOMAL LYSO-PHOSPHATIDYLSERINE ACTIVATES TOLL-LIKE RECEPTOR 2 AND AFFECTS IMMUNE POLARIZATION. J. Biol. Chem.
277: 48122-48129
[Abstract]
[Full Text]
-
Faveeuw, C., Angeli, V., Fontaine, J., Maliszewski, C., Capron, A., Van Kaer, L., Moser, M., Capron, M., Trottein, F.
(2002). Antigen Presentation by CD1d Contributes to the Amplification of Th2 Responses to Schistosoma mansoni Glycoconjugates in Mice. J. Immunol.
169: 906-912
[Abstract]
[Full Text]
-
Ross, A. G. P., Sleigh, A. C., Li, Y., Davis, G. M., Williams, G. M., Jiang, Z., Feng, Z., McManus, D. P.
(2001). Schistosomiasis in the People's Republic of China: Prospects and Challenges for the 21st Century. Clin. Microbiol. Rev.
14: 270-295
[Abstract]
[Full Text]
-
Rodrigues, M. L., Travassos, L. R., Miranda, K. R., Franzen, A. J., Rozental, S., de Souza, W., Alviano, C. S., Barreto-Bergter, E.
(2000). Human Antibodies against a Purified Glucosylceramide from Cryptococcus neoformans Inhibit Cell Budding and Fungal Growth. Infect. Immun.
68: 7049-7060
[Abstract]
[Full Text]